Compare · head to head
Avadel Pharmaceuticals vs Dottikon
Avadel Pharmaceuticals ranks higher overall — 360 rank 70 vs 34.
Avadel Pharmaceuticals leads on Value (44 vs 28) and Quality (78 vs 36). Dottikon leads on Sentiment (49 vs 39). The two are close on Safety.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | Ireland | Switzerland |
| Sector | Health Care | Health Care |
| Industry | Pharmaceuticals | Pharmaceuticals |
| Size | Small | Medium |
| ISIN | IE00BDGMC594 | CH0582581713 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 70 | 34 |
| Value | 44 | 28 |
| Quality | 78 | 36 |
| Growth | NR | 60 |
| Safety | 60 | 61 |
| Sentiment | 39 | 49 |
| Quality details | ||
| Profitability | 74 | 38 |
| Cash Truth | 81 | 33 |
Avadel Pharmaceuticals vs Jazz PharmaceuticalsAvadel Pharmaceuticals vs Cosmo PharmaceuticalsAvadel Pharmaceuticals vs VirbacAvadel Pharmaceuticals vs SandozAdd a third stock →
Full analyses: Avadel Pharmaceuticals · Dottikon
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100